Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial Prof Sarah G Staedke, PhD, Catherine Maiteki-Sebuguzi, MSc, Andrea M Rehman, PhD, Simon P Kigozi, MSc, Samuel Gonahasa, MBChB, Jaffer Okiring, MSc, Prof Steve W Lindsay, PhD, Prof Moses R Kamya, PhD, Clare I R Chandler, PhD, Prof Grant Dorsey, PhD, Prof Chris Drakeley, PhD The Lancet Global Health Volume 6, Issue 6, Pages e668-e679 (June 2018) DOI: 10.1016/S2214-109X(18)30126-8 Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license Terms and Conditions
Figure 1 Map of study area The study included 84 clusters, each including one primary school and the closest available 100 surrounding households. IPT=intermittent preventive treatment. The Lancet Global Health 2018 6, e668-e679DOI: (10.1016/S2214-109X(18)30126-8) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license Terms and Conditions
Figure 2 Trial profile IPT=intermittent preventive treatment. DP=dihydroartemisinin-piperaquine. AL=artemether-lumefantrine. *One household was excluded and replaced with a newly recruited household. The Lancet Global Health 2018 6, e668-e679DOI: (10.1016/S2214-109X(18)30126-8) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license Terms and Conditions